ADCYAP1 and glioblastoma: In our investigations, we found that PACAP also abrogated the aberrant EGFR transactivation occurring in GBM cells cultured in hypoxia, probably through inhibition of PI3K/Akt and MAPK/ERK pathway (Figure 1).